KUALA LUMPUR: Apex Healthcare Bhd
’s Singapore subsidiary First SGC Pte Ltd has subscribed for a 40% stake in a joint venture (JV) company with Shanghai Pharmaceutical Import & Export Co Ltd for S$1.2mil (RM3.9mil).
In a filing with Bursa Malaysia, Apex said Shanghai Pharmaceutical would own the remaining 60% of the JV company, which is yet to be incorporated. The move is to commercialise branded pharmaceuticals, consumer healthcare products and medical devices from the SPH and AHB Group under the brand of the JV Co in Asean.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
